Showing all 4 results
Isoxsuprine Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended Immediate-Release or Sustained-Release Tablet, packed exclusively in highly secure, moisture-resistant Alu-PVC or Alu-Alu blister strips to ensure the absolute chemical stability of the active pharmaceutical ingredient.
Active Ingredient Strength Primary Clinical Function Isoxsuprine Hydrochloride USP/Ph.Eur. 10 mg (IR) Acute Titration Standard: Immediate-release base unit used for the rapid initiation of therapy or carefully titrated maintenance in sensitive patients. Isoxsuprine Hydrochloride USP/Ph.Eur. 40 mg (SR) Obstetrics Maintenance Standard: High-efficacy, slow-release matrix designed specifically to provide 12-hour continuous tocolysis, vastly improving maternal compliance and protecting the cardiovascular system. Excipients Hypromellose (HPMC) / Microcrystalline Cellulose / Lactose Monohydrate / Colloidal Silicon Dioxide / Magnesium Stearate ER Polymer / Diluent / Binder / Glidant / Lubricant (Engineered specifically utilizing premium Hypromellose matrices in the 40mg variant to form a robust hydrogel that slowly erodes in the gastrointestinal tract, ensuring steady-state plasma levels) *Pack Sizes: 10×10 Blisters (Optimized specifically for strict obstetric and chronic vascular dispensing regimens).
Lithium Carbonate Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, High-Density Tablet, packed exclusively in highly secure, moisture-resistant Alu-PVC or Alu-Alu blister strips to ensure the absolute physical stability of the controlled-release polymers.
Active Ingredient Strength Primary Clinical Function Lithium Carbonate USP/Ph.Eur. 300 mg (IR) Acute Mania Standard: Immediate-release base unit used for the rapid, aggressive titration of serum lithium levels during an active, severe manic episode. Lithium Carbonate USP/Ph.Eur. 400 mg / 450 mg (ER/SR) Global Maintenance Standard: Extended-release therapy designed to flatten the pharmacokinetic curve, preventing toxic blood spikes and minimizing severe hand tremors and nausea during lifelong maintenance therapy. Excipients Hypromellose (HPMC) / Microcrystalline Cellulose / Sodium Starch Glycolate / Magnesium Stearate / Premium Opadry Film Hydrophilic ER Polymer / Diluent / Disintegrant / Lubricant (Engineered specifically using high-shear wet granulation to form a highly reliable, slow-eroding matrix that trickles the elemental lithium into the bloodstream over 12 hours) *Pack Sizes: Bottles of 100 or 10×10 Blisters (Optimized specifically for strict, massive-volume lifelong psychiatric dispensing regimens).
Mirabegron Extended-Release Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Hydrophilic Matrix ER Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips to ensure the absolute physical stability of the extended-release polymers.
Active Ingredient Strength Primary Clinical Function Mirabegron Ph.Eur./USP 25 mg (ER) Initiation / Renal Standard: Base therapeutic unit for assessing patient tolerance and for use in patients with severe renal or hepatic impairment. Mirabegron Ph.Eur./USP 50 mg (ER) Global Urology Standard: High-efficacy adult maintenance therapy for maximum suppression of urge urinary incontinence and detrusor overactivity. Excipients Polyethylene Oxide / Hypromellose (HPMC) / Butylated Hydroxytoluene (BHT) / Magnesium Stearate / Premium Opadry Film Swellable ER Polymer / Hydrophilic Matrix Base / Antioxidant / Lubricant (Engineered specifically to form an impenetrable, slow-eroding gel matrix in the GI tract, strictly metering the release of the active ingredient over 24 hours) *Pack Sizes: 10×10 Alu-Alu Blisters or Bottles of 30 (Optimized specifically for strict 30-day chronic urology dispensing regimens).
Morphine Sulphate SR Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Extended-Release Matrix Tablet, packed exclusively in highly secure, tamper-evident Alu-PVC or Alu-Alu blister strips to ensure the absolute physical stability of the controlled-release polymers.
Active Ingredient Strength Primary Clinical Function Morphine Sulphate USP/Ph.Eur. 15 mg (SR) Initiation / Titration Standard: Base therapeutic unit for opioid-naïve patients starting around-the-clock chronic pain management. Morphine Sulphate USP/Ph.Eur. 30 mg / 60 mg (SR) Global Oncology Standard: High-dose adult maintenance therapy for severe, opioid-tolerant terminal cancer and intractable neuropathic pain. Excipients Hypromellose (HPMC) / Cetostearyl Alcohol / Lactose Monohydrate / Magnesium Stearate / Premium Color-Coded Film Hydrophilic Polymer / Lipophilic Retardant / Diluent / Lubricant (Engineered specifically to form an impenetrable, slow-eroding gel matrix in the GI tract, strictly metering the release of the narcotic over 12 hours) *Pack Sizes: 10×10 Blisters (Optimized specifically for strict 30-day chronic oncology dispensing regimens; frequently color-coded by strength to prevent fatal dispensing errors).
